Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gemcitabine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03883919
What this trial is testing

Liposomal Irinotecan Plus 5-FU / LV Combined With Paricalcitol in Patients With Advanced Pancreatic Cancer Progressed on Gemcitabine-based Therapy

Who this might be right for
Pancreatic CancerPancreas CancerCancer of the Pancreas
Washington University School of Medicine 20
Testing effectiveness (Phase 2)Study completedNCT00754351
What this trial is testing

Docetaxel, Gemcitabine and Bevacizumab for Metastatic Breast Cancer

Who this might be right for
Breast Cancer
University Hospital of Crete 48
Early research (Phase 1)Study completedNCT02154737
What this trial is testing

Gemcitabine and Pulse Dose Erlotinib in Second Line Treatment of Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Tony Reid, M.D., Ph.D. 24
Testing effectiveness (Phase 2)Study completedNCT00061477
What this trial is testing

Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal Mesothelioma

Who this might be right for
Mesothelioma
Eli Lilly and Company 48
Early research (Phase 1)Ended earlyNCT04131192
What this trial is testing

Gemcitabine and Z650 in Treating Patients With Metastatic or Recurrent Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Sunshine Lake Pharma Co., Ltd. 13
Testing effectiveness (Phase 2)Ended earlyNCT00055432
What this trial is testing

Gemzar (Gemcitabine) and Alimta (Pemetrexed) in the Treatment of Patients With Recurrent Platinum-Sensitive and Platinum-Resistant Ovarian or Peritoneal Cancer

Who this might be right for
Ovarian CancerPeritoneal Cancer
Eli Lilly and Company
Testing effectiveness (Phase 2)Looking for participantsNCT03364530
What this trial is testing

Hepatic Arterial Infusion of Gemcitabine-oxaliplatin for Second-line Therapy in Non-metastatic Unresectable Intra-hepatic Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma Non-resectableNon-metastatic
University Hospital, Montpellier 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07808216
What this trial is testing

Toripalimab Combined With Intravesical Gemcitabine as Adjuvant Therapy for High-Risk Non-Muscle-Invasive Bladder Cancer After TURBT

Who this might be right for
Non Muscle Invasive Bladder Cancer
Tianjin First Central Hospital 54
Early research (Phase 1)Study completedNCT00678132
What this trial is testing

AZD2281 and Cisplatin Plus Gemcitabine to Treat Solid Tumor Cancers

Who this might be right for
Neoplasms
National Cancer Institute (NCI) 23
Testing effectiveness (Phase 2)Study completedNCT03558087
What this trial is testing

Gemcitabine, Cisplatin, Plus Nivolumab in Patients With Muscle-invasive Bladder Cancer With Selective Bladder Sparing

Who this might be right for
Bladder Cancer
Matthew Galsky 76
Testing effectiveness (Phase 2)Study completedNCT00948935
What this trial is testing

Study of Gemcitabine, Irinotecan and Panitumumab in Patients With Advanced and Metastatic Biliary Tract Adenocarcinoma

Who this might be right for
Biliary CancerCholangiocarcinoma
Abramson Cancer Center at Penn Medicine 35
Early research (Phase 1)Study completedNCT00954525
What this trial is testing

Intravenous Vitamin C in Combination With Standard Chemotherapy for Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 14
Testing effectiveness (Phase 2)Ended earlyNCT00323791
What this trial is testing

Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer

Who this might be right for
Kidney Cancer
University of Medicine and Dentistry of New Jersey 100
Testing effectiveness (Phase 2)Looking for participantsNCT06423326
What this trial is testing

Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic Ductal AdenocarcinomaResectable Pancreatic AdenocarcinomaStage I Pancreatic Cancer AJCC v8+2 more
Emory University 36
Testing effectiveness (Phase 2)Looking for participantsNCT06822010
What this trial is testing

SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma

Who this might be right for
Urinary Bladder CancerUpper Tract Urothelial CancerUrothelial Cancer
Rutgers, The State University of New Jersey 28
Large-scale testing (Phase 3)Study completedNCT00190710
What this trial is testing

A Trial of Carboplatin and Gemcitabine Versus Gemcitabine Alone in Patients With Non-Small-Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Eli Lilly and Company 242
Very early researchStudy completedNCT02992015
What this trial is testing

Gemcitabine in Newly-Diagnosed Diffuse Intrinsic Pontine Glioma

Who this might be right for
Diffuse Intrinsic Pontine Glioma
University of Colorado, Denver 2
Testing effectiveness (Phase 2)Ended earlyNCT01050426
What this trial is testing

A Clinical Study of UFT/Leucovorin, Radiotherapy With or Without Cetuximab Following Induction Gemcitabine Plus Capecitabine in Patients With Locally Advanced Pancreatic Cancer (PERU)

Who this might be right for
Pancreatic Cancer
Royal Marsden NHS Foundation Trust 17
Testing effectiveness (Phase 2)Study completedNCT00191490
What this trial is testing

Study Evaluating the Feasibility and Activity of Three Different Combination With Gemcitabine as First Line Therapy for Non Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Eli Lilly and Company 162
Large-scale testing (Phase 3)Study completedNCT00191438
What this trial is testing

Phase III Study of Gemcitabine Plus a Cytotoxic Agent Versus Two Cytotoxic Agents

Who this might be right for
Breast Neoplasms
Eli Lilly and Company 300
Next Page